Navigation
Hair Loss News Archives
November 2010
New test helps determine best treatment for hair loss in women
The test was unveiled to physicians at the International Society of Hair Restoration Surgery
Nov 2010
A new test can help doctors determine whether a woman experiencing
hair loss is likely to benefit from antiandrogen therapies.
According to dermatology research and development company
DermaGenoma, the HairDX Genetic Test for Female Androgen Sensitivity
offers a new genetic screening for women suffering from or at risk
of androgenetic alopecia (AGA).
The test was unveiled to physicians at the
International Society of Hair Restoration Surgery’s 18th Annual
Scientific Meeting, held in Boston in October.
The test examines genetic and epigenetic variations in a woman’s
androgen receptor gene, then assesses her androgen sensitivity to
determine if her hair loss has an androgenic origin.
Patients with high androgen sensitivity could benefit from
antiandrogen therapies. Understanding the origin of the hair loss
will help physicians select the most effective treatment, the
company says.
Source